Qiong Fu

2.8k total citations · 1 hit paper
64 papers, 1.7k citations indexed

About

Qiong Fu is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Qiong Fu has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 24 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Qiong Fu's work include Systemic Lupus Erythematosus Research (17 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and T-cell and B-cell Immunology (13 papers). Qiong Fu is often cited by papers focused on Systemic Lupus Erythematosus Research (17 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and T-cell and B-cell Immunology (13 papers). Qiong Fu collaborates with scholars based in China, United States and France. Qiong Fu's co-authors include Chunde Bao, Qiang Guo, Nan Shen, Liangjing Lu, Ran Wang, Min Dai, Qingran Yan, Huijuan Cui, Sheng Chen and Xinyue Lian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Qiong Fu

59 papers receiving 1.7k citations

Hit Papers

Treatment of knee osteoarthritis with intra-articular inj... 2019 2026 2021 2023 2019 50 100 150

Peers

Qiong Fu
So‐Young Bang South Korea
Qiong Fu
Citations per year, relative to Qiong Fu Qiong Fu (= 1×) peers So‐Young Bang

Countries citing papers authored by Qiong Fu

Since Specialization
Citations

This map shows the geographic impact of Qiong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiong Fu more than expected).

Fields of papers citing papers by Qiong Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiong Fu. The network helps show where Qiong Fu may publish in the future.

Co-authorship network of co-authors of Qiong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiong Fu. A scholar is included among the top collaborators of Qiong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiong Fu. Qiong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, Lin Fang, Jinjuan Zhang, et al.. (2025). The spice clove effectively ameliorated hyperuricemia and hyperuricemia-induced kidney injury in mice. Journal of Agriculture and Food Research. 20. 101760–101760. 1 indexed citations
2.
Shen, Chen‐Yang & Qiong Fu. (2025). Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics. Frontiers in Immunology. 16. 1686687–1686687.
3.
Xu, Wenwen, et al.. (2025). Spontaneous pneumomediastinum and/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system. Respiratory Research. 26(1). 281–281.
4.
Li, Jingjing, Ran Wang, Jie Chen, et al.. (2025). Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome. Frontiers in Immunology. 16. 1604648–1604648.
5.
Castellini, Chiara, Claudia Scotti, Luca Navarini, et al.. (2024). The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis. Autoimmunity Reviews. 23(12). 103686–103686. 4 indexed citations
6.
7.
Liu, Qian, Qiong Fu, Qian Jiang, et al.. (2024). Curation, nomenclature, and topological classification of receptor-like kinases from 528 plant species for novel domain discovery and functional inference. Molecular Plant. 17(4). 658–671. 3 indexed citations
8.
Fu, Yakai, Liyang Gu, Yuting Dai, et al.. (2024). Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody. RMD Open. 10(1). e003901–e003901. 8 indexed citations
9.
Wang, Yiyang, Liangjing Lu, Shuang Ye, & Qiong Fu. (2024). CAR-based cell therapies for systemic lupus erythematosus. Chinese Medical Journal. 138(5). 523–530. 3 indexed citations
10.
Fu, Qiong, Qian Liu, Jia Chen, et al.. (2024). Large-scale analysis of the N-terminal regulatory elements of the kinase domain in plant Receptor-like kinase family. BMC Plant Biology. 24(1). 174–174. 3 indexed citations
11.
Jiang, Meng, et al.. (2023). Erucic acid improves the progress of pregnancy complicated with systemic lupus erythematosus by inhibiting the effector function of CD8+ T cells. SHILAP Revista de lepidopterología. 4(5). e382–e382. 7 indexed citations
12.
Zhang, Zhiliang, Qiong Fu, Chunde Bao, et al.. (2023). Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Research & Therapy. 25(1). 151–151. 3 indexed citations
13.
Zhu, Sirui, Yuanyuan Li, You Wu, et al.. (2023). The FERONIA-YUELAO module participates in translational control by modulating the abundance of tRNA fragments in Arabidopsis. Developmental Cell. 58(24). 2930–2946.e9. 5 indexed citations
14.
Chen, Weijun, Huina Zhou, Fan Xu, et al.. (2022). CAR modulates plasma membrane nano‐organization and immune signaling downstream of RALF1‐FERONIA signaling pathway. New Phytologist. 237(6). 2148–2162. 16 indexed citations
15.
Zhu, Sirui, Qiong Fu, Fan Xu, Heping Zheng, & Feng Yu. (2021). New paradigms in cell adaptation: decades of discoveries on the CrRLK1L receptor kinase signalling network. New Phytologist. 232(3). 1168–1183. 70 indexed citations
16.
Jiang, Meng, et al.. (2021). High-risk factors for adverse pregnancy outcomes in systemic lupus erythaematosus: a retrospective study of a Chinese population. BMJ Open. 11(11). e049807–e049807. 12 indexed citations
17.
Fu, Qiong & Xiaoming Zhang. (2021). From blood to tissue: take a deeper look at B cells in lupus. Cellular and Molecular Immunology. 18(8). 2073–2074. 5 indexed citations
18.
Yan, Ye, Mei Liu, Fang Du, et al.. (2019). Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Research & Therapy. 21(1). 92–92. 36 indexed citations
19.
Chen, Jie, Shuhui Sun, Qingran Yan, Chunde Bao, & Qiong Fu. (2016). Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study. Clinical Rheumatology. 35(2). 333–340. 12 indexed citations
20.
Yan, Qingran, Fang Du, Xinfang Huang, et al.. (2014). Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice. PLoS ONE. 9(10). e108273–e108273. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026